Journal of Medicinal Chemistry · 2015 · 51 citations · 62 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyChemotherapyDrug DiscoveryCytotoxic ChemotherapyMicrotubule-associated ProteinsMicrotubule-targeting AgentsOncology PharmacologyColchicine Site BindingColchicine-binding Site LigandsDrug Binding Sites On TubulinMicrotubule Inhibitor ResistanceMicrotubule Polymerization InhibitionTherapeutic Growth InhibitionTubulin Binding SitesTubulin Polymerization Inhibitors
A number of indole-3-glyoxylamides have previously been reported as tubulin polymerization inhibitors, although none has yet been successfully developed clinically. We report here a new series of related compounds, modified according to a strategy of reducing aromatic ring count and introducing a greater degree of saturation, which retain potent tubulin polymerization activity but with a distinct SAR from previously documented libraries. A subset of active compounds from the reported series is shown to interact with tubulin at the colchicine binding site, disrupt the cellular microtubule network, and exert a cytotoxic effect against multiple cancer cell lines. Two compounds demonstrated significant tumor growth inhibition in a mouse xenograft model of head and neck cancer, a type of the disease which often proves resistant to chemotherapy, supporting further development of the current series as potential new therapeutics.
62
Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations
Medicine, Oncology, Pharmacotherapy +13
Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 633 citations
Medicine, Oncology, Pharmacology +11